It is particularly important to identify the different stages of renal fibrosis and select the timing of targeted therapy, which poses a greater challenge to the targeted MCP-1/CCR2 axis in the treatment of renal fibrosis. The gene discussed is CCL2; the disease is renal fibrosis.